Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Sublingual Immunotherapy With Mite Extract in Patients With Atopic Dermatits: Placebo-controlled Double-blind Randomized Study

NCT03388866 is registered in ClinicalTrials.gov with Casa Espirita Terra de Ismael as lead sponsor.

NCT NCT03388866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03388866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Sublingual Immunotherapy With Mite Extract in Patients With Atopic Dermatits: Placebo-controlled Double-blind Randomized Study
Lead sponsor
Casa Espirita Terra de Ismael
Phase
Phase 4
Overall status
Completed
Start date
May 2, 2018
Completion date
June 26, 2020
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, effects of immunotherapy